IRMD Iradimed Corp

iRadimed Corp develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally.

$44.29  -1.14 (-2.51%)
As of 12/03/2021 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  07/16/2014
Outstanding shares:  12,341,750
Average volume:  97,544
Market cap:   $560,685,703
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    46266A109
ISIN:        US46266A1097
Sedol:      BP4GNJ8
Valuation   (See tab for details)
PE ratio:   90.29
PB ratio:   8.07
PS ratio:   14.57
Return on equity:   8.94%
Net income %:   15.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy